120 related articles for article (PubMed ID: 31953612)
21. Waiting Time from Diagnosis to Treatment has no Impact on Survival in Patients with Esophageal Cancer.
Visser E; Leeftink AG; van Rossum PS; Siesling S; van Hillegersberg R; Ruurda JP
Ann Surg Oncol; 2016 Aug; 23(8):2679-89. PubMed ID: 27012988
[TBL] [Abstract][Full Text] [Related]
22. [Prognostic value of the tumor deposit in N0 gastric cancer by propensity score matching analysis].
Zhi C; Yang W; Li N; Zhang Z; Hua Y; Liu H
Zhonghua Wei Chang Wai Ke Za Zhi; 2019 Feb; 22(2):172-179. PubMed ID: 30799540
[TBL] [Abstract][Full Text] [Related]
23. The impact and optimal indication of non-curative gastric resection for stage IV advanced gastric cancer diagnosed during surgery: 10 years of experience at a single institute.
Yamada N; Akai A; Nomura Y; Tanaka N
World J Surg Oncol; 2016 Mar; 14():79. PubMed ID: 26965446
[TBL] [Abstract][Full Text] [Related]
24. Poor survival rate in patients with postoperative intra-abdominal infectious complications following curative gastrectomy for gastric cancer.
Tokunaga M; Tanizawa Y; Bando E; Kawamura T; Terashima M
Ann Surg Oncol; 2013 May; 20(5):1575-83. PubMed ID: 23076557
[TBL] [Abstract][Full Text] [Related]
25. Modest overall survival improvements from 1998 to 2009 in metastatic gastric cancer patients: a population-based SEER analysis.
Ebinger SM; Warschkow R; Tarantino I; Schmied BM; Güller U; Schiesser M
Gastric Cancer; 2016 Jul; 19(3):723-34. PubMed ID: 26391158
[TBL] [Abstract][Full Text] [Related]
26. Does non-curative gastrectomy improve survival in patients with metastatic gastric cancer?
Kokkola A; Louhimo J; Puolakkainen P
J Surg Oncol; 2012 Aug; 106(2):193-6. PubMed ID: 22354864
[TBL] [Abstract][Full Text] [Related]
27. Prognostic Role of Conversion Surgery for Unresectable Gastric Cancer.
Fukuchi M; Ishiguro T; Ogata K; Suzuki O; Kumagai Y; Ishibashi K; Ishida H; Kuwano H; Mochiki E
Ann Surg Oncol; 2015 Oct; 22(11):3618-24. PubMed ID: 25663597
[TBL] [Abstract][Full Text] [Related]
28. Adjuvant radiotherapy improves overall survival in patients with resected gastric adenocarcinoma: A National Cancer Data Base analysis.
Stumpf PK; Amini A; Jones BL; Koshy M; Sher DJ; Lieu CH; Schefter TE; Goodman KA; Rusthoven CG
Cancer; 2017 Sep; 123(17):3402-3409. PubMed ID: 28513823
[TBL] [Abstract][Full Text] [Related]
29. Effect of perioperative blood transfusion on prognosis of patients with gastric cancer: a retrospective analysis of a single center database.
Liu X; Ma M; Huang H; Wang Y
BMC Cancer; 2018 Jun; 18(1):649. PubMed ID: 29890957
[TBL] [Abstract][Full Text] [Related]
30. Comparison of five tumor regression grading systems for gastric adenocarcinoma after neoadjuvant chemotherapy: a retrospective study of 192 cases from National Cancer Center in China.
Zhu Y; Sun Y; Hu S; Jiang Y; Yue J; Xue X; Yang L; Xue L
BMC Gastroenterol; 2017 Mar; 17(1):41. PubMed ID: 28292272
[TBL] [Abstract][Full Text] [Related]
31. [Survival comparison of Siewert II adenocarcinoma of esophagogastric junction between transthoracic and transabdominal approaches:a joint data analysis of thoracic and gastrointestinal surgery].
Yang S; Yuan Y; Hu H; Li R; Liu K; Zhang W; Yang K; Yang Y; Bai D; Chen X; Zhou Z; Chen L
Zhonghua Wei Chang Wai Ke Za Zhi; 2019 Feb; 22(2):132-142. PubMed ID: 30799535
[TBL] [Abstract][Full Text] [Related]
32. [Clinical value of superior mesenteric vein (No.14v) lymph node dissection in D2 gastrectomy for locally advanced distal gastric cancer].
Lu W; Zeng X; Li N; Liu H
Zhonghua Wei Chang Wai Ke Za Zhi; 2018 Oct; 21(10):1136-1141. PubMed ID: 30370512
[TBL] [Abstract][Full Text] [Related]
33. Conversion surgery for gastric cancer: A cohort study from a western center.
Morgagni P; Solaini L; Framarini M; Vittimberga G; Gardini A; Tringali D; Valgiusti M; Monti M; Ercolani G
Int J Surg; 2018 May; 53():360-365. PubMed ID: 29654967
[TBL] [Abstract][Full Text] [Related]
34. Outcomes of surgery for gastric cancer with distant metastases: a retrospective study from the SEER database.
Chen J; Kong Y; Weng S; Dong C; Zhu L; Yang Z; Zhong J; Yuan Y
Oncotarget; 2017 Jan; 8(3):4342-4351. PubMed ID: 28008147
[TBL] [Abstract][Full Text] [Related]
35. Does hipec improve outcomes in gastric cancer patients treated with perioperative chemotherapy and radical surgery? A propensity-score matched analysis.
Diniz TP; da Costa WL; Fonseca de Jesus VH; Ribeiro HSC; Diniz AL; de Godoy AL; de Farias IC; Torres SM; Felismino TC; Coimbra FJF
J Surg Oncol; 2020 Apr; 121(5):823-832. PubMed ID: 31950511
[TBL] [Abstract][Full Text] [Related]
36. [Clinicopathological characteristics of gastric cancer in adolescents aged 10-24 years: 17-year experience of 17 years in a single institute].
Zhang W; Liang WQ; Cai AZ; Wang PP; Xi HQ; Liu GX; Wei B
Zhonghua Wei Chang Wai Ke Za Zhi; 2020 Oct; 23(10):963-968. PubMed ID: 33053991
[No Abstract] [Full Text] [Related]
37. Waiting time for cancer treatment and mental health among patients with newly diagnosed esophageal or gastric cancer: a nationwide cohort study.
Song H; Fang F; Valdimarsdóttir U; Lu D; Andersson TM; Hultman C; Ye W; Lundell L; Johansson J; Nilsson M; Lindblad M
BMC Cancer; 2017 Jan; 17(1):2. PubMed ID: 28049452
[TBL] [Abstract][Full Text] [Related]
38. Adenocarcinoma in the middle third of the stomach--an evaluation for the prognostic significance of clinicopathological features.
Sheen-Chen SM; Chou CW; Chen MC; Chen FC; Chen YS; Chen JJ
Hepatogastroenterology; 1997; 44(17):1488-94. PubMed ID: 9356878
[TBL] [Abstract][Full Text] [Related]
39. [Prognostic factors of lymph node-negative metastasis gastric cancer].
Sun D; Xu H; Huang J
Zhonghua Wei Chang Wai Ke Za Zhi; 2017 Feb; 20(2):190-194. PubMed ID: 28226354
[TBL] [Abstract][Full Text] [Related]
40. Prognostic value of perioperative leukocyte count in resectable gastric cancer.
Chen XF; Qian J; Pei D; Zhou C; Røe OD; Zhu F; He SH; Qian YY; Zhou Y; Xu J; Xu J; Li X; Ping GQ; Liu YQ; Wang P; Guo RH; Shu YQ
World J Gastroenterol; 2016 Mar; 22(9):2818-27. PubMed ID: 26973420
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
